Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

These biologics, which include monoclonal antibodies, cancer growth inhibitors, gene therapies, and vaccines, among others, have revolutionized the way cancer is treated. The significance of the ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

CTLA4 Inhibitors Market forecast to 2035 covers market size, key trends, competitive landscape, and growth opportunities in cancer immunotherapy and autoimmune diseases.

Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

KAIST researchers isolated DDX54 as the master regulator that hinders the effectiveness of immunotherapy—opening a new path ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...